Suk-Joon Chang Selected Research

Colpotomy

3/2022	Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol.
12/2021	Solution to prevent tumor spillage in minimally invasive radical hysterectomy using the endoscopic stapler for treating early-stage cervical cancer: Surgical technique with video.
9/2020	Prognostic factors influencing pelvic, extra-pelvic, and intraperitoneal recurrences in lymph node-negative early-stage cervical cancer patients following radical hysterectomy.
1/2016	Patterns of recurrence and survival after abdominal versus laparoscopic/robotic radical hysterectomy in patients with early cervical cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suk-Joon Chang Research Topics

Disease

25	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2022 - 03/2009
21	Neoplasms (Cancer) 03/2022 - 01/2008
18	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 09/2008
9	Endometrial Neoplasms (Endometrial Cancer) 09/2021 - 01/2008
7	Lymphatic Metastasis 11/2016 - 12/2010
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2022 - 10/2005
6	Carcinoma (Carcinomatosis) 01/2016 - 06/2008
5	Ovarian Epithelial Carcinoma 01/2022 - 01/2016
2	Disease Progression 01/2022 - 01/2022
2	Residual Neoplasm 01/2022 - 12/2012
2	Margins of Excision 09/2020 - 05/2010
2	Hemorrhage 06/2019 - 03/2016
2	Anemia 10/2018 - 10/2017
2	Lymphopenia (Lymphocytopenia) 10/2017 - 07/2016
1	Hypoxia (Hypoxemia) 12/2022
1	Fistula 06/2022
1	Adenocarcinoma 03/2022
1	Adenosquamous Carcinoma 03/2022
1	Malignant Mesothelioma 01/2022
1	Pseudomyxoma Peritonei 01/2022
1	Ovarian Teratoma 10/2021
1	Encephalitis (Encephalitis, Rasmussen) 10/2021
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 10/2021
1	Teratoma (Teratoid Tumor) 10/2021
1	Lymphedema (Milroy Disease) 09/2021
1	Anastomotic Leak 06/2019
1	Sepsis (Septicemia) 10/2018
1	Thrombocytopenia (Thrombopenia) 10/2018
1	Fever (Fevers) 10/2018
1	Septic Shock (Toxic Shock Syndrome) 10/2018
1	Lymphocele 08/2016
1	Endometrioid Carcinoma 06/2016
1	Female Genital Diseases 03/2016
1	Pneumoperitoneum 01/2016
1	Endometriosis 01/2016
1	Uterine Cervical Dysplasia 12/2014
1	Adenocarcinoma in Situ 12/2014
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Endometrial Hyperplasia 03/2010
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2010

Drug/Important Bio-Agent (IBA)

6	PlatinumIBA 01/2022 - 09/2008
6	squamous cell carcinoma-related antigenIBA 10/2017 - 10/2005
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2012
3	Indicators and Reagents (Reagents)IBA 10/2018 - 03/2010
3	Hemoglobins (Hemoglobin)IBA 10/2017 - 03/2016
3	antigen CYFRA21.1IBA 01/2016 - 10/2005
2	SolutionsIBA 03/2022 - 12/2021
2	AntigensIBA 11/2016 - 01/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2014 - 05/2012
2	taxaneIBA 09/2013 - 09/2012
1	Carbonic Anhydrase IXIBA 12/2022
1	RNA (Ribonucleic Acid)IBA 12/2022
1	Bevacizumab (Avastin)FDA Link 06/2022
1	Checkpoint Kinase 2IBA 01/2022
1	PHI-101IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Hormones (Hormone)IBA 01/2016
1	micaIBA 12/2014
1	4,6- anhydrogalactopyranosyl- 6- O- corynomycoloylgalactopyranosideIBA 09/2014
1	Fluorouracil (Carac)FDA LinkGeneric 10/2012
1	Syndecan-1 (Syndecan 1)IBA 03/2010
1	Proteoglycans (Proteoglycan)IBA 03/2010

Therapy/Procedure

22	Hysterectomy 03/2022 - 06/2008
14	Lymph Node Excision (Lymph Node Dissection) 09/2021 - 01/2008
13	Cytoreduction Surgical Procedures 01/2022 - 09/2008
10	Drug Therapy (Chemotherapy) 06/2022 - 09/2008
7	Therapeutics 09/2021 - 10/2012
5	Adjuvant Chemotherapy 10/2018 - 01/2008
5	Chemoradiotherapy 10/2017 - 07/2013
4	Radiotherapy 06/2022 - 07/2013
4	Colpotomy 03/2022 - 01/2016
4	Neoadjuvant Therapy 01/2022 - 01/2016
4	Brachytherapy 10/2017 - 01/2012
3	Trachelectomy 09/2014 - 06/2012
2	Hyperthermic Intraperitoneal Chemotherapy 01/2022 - 01/2022
2	Colectomy 06/2019 - 01/2019
2	Salpingo-oophorectomy 12/2010 - 09/2009
1	Palliative Care (Palliative Therapy) 01/2022
1	Minimally Invasive Surgical Procedures 12/2021
1	Operative Surgical Procedures 12/2021
1	Immunotherapy 10/2021
1	Cholecystectomy 03/2021
1	Operative Time 06/2019
1	Splenectomy 10/2018
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 08/2016
1	Adjuvant Radiotherapy 06/2012
1	Combination Drug Therapy (Combination Chemotherapy) 05/2012
1	Laparotomy 06/2010
1	Conservative Treatment 05/2010
1	Length of Stay 01/2008